Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trialRobin Kate Kelley, Ming‐Huang Chen, Thomas Yau et al.|The Lancet|2023Cited by 1k
HER2/neu-directed therapy for biliary tract cancerMilind Javle, Abby B. Siegel|Journal of Hematology & Oncology|2015Cited by 223
The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitisMarcela Salomao, Roger K. Moreira, Helen Remotti et al.|Human Pathology|2011Cited by 175